BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 27565576)

  • 21. Carboplatin chemoresistance is associated with CD11b
    Anestakis D; Petanidis S; Domvri K; Tsavlis D; Zarogoulidis P; Katopodi T
    Mol Immunol; 2020 Feb; 118():99-109. PubMed ID: 31862674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune checkpoint status and exhaustion-related phenotypes of CD8
    Yilmaz I; Tavukcuoglu E; Horzum U; Yilmaz KB; Akinci M; Gulcelik MA; Oral HB; Esendagli G
    Cancer Med; 2023 Dec; 12(24):22196-22205. PubMed ID: 38069525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-infiltrating regulatory T cells delineated by upregulation of PD-1 and inhibitory receptors.
    Park HJ; Kusnadi A; Lee EJ; Kim WW; Cho BC; Lee IJ; Seong J; Ha SJ
    Cell Immunol; 2012; 278(1-2):76-83. PubMed ID: 23121978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decrease of T-cells exhaustion markers programmed cell death-1 and T-cell immunoglobulin and mucin domain-containing protein 3 and plasma IL-10 levels after successful treatment of chronic hepatitis C.
    Osuch S; Laskus T; Berak H; Perlejewski K; Metzner KJ; Paciorek M; Radkowski M; Caraballo Cortés K
    Sci Rep; 2020 Sep; 10(1):16060. PubMed ID: 32994477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD8
    Wang M; Bu J; Zhou M; Sido J; Lin Y; Liu G; Lin Q; Xu X; Leavenworth JW; Shen E
    Clin Immunol; 2018 May; 190():64-73. PubMed ID: 28893624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT.
    Noviello M; Manfredi F; Ruggiero E; Perini T; Oliveira G; Cortesi F; De Simone P; Toffalori C; Gambacorta V; Greco R; Peccatori J; Casucci M; Casorati G; Dellabona P; Onozawa M; Teshima T; Griffioen M; Halkes CJM; Falkenburg JHF; Stölzel F; Altmann H; Bornhäuser M; Waterhouse M; Zeiser R; Finke J; Cieri N; Bondanza A; Vago L; Ciceri F; Bonini C
    Nat Commun; 2019 Mar; 10(1):1065. PubMed ID: 30911002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased TOX expression concurrent with PD-1, Tim-3, and CD244 expression in T cells from patients with acute myeloid leukemia.
    Huang S; Liang C; Zhao Y; Deng T; Tan J; Zha X; Li Y; Chen S
    Cytometry B Clin Cytom; 2022 Mar; 102(2):143-152. PubMed ID: 34913594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retroviral transduction of acute myeloid leukaemia-derived dendritic cells with OX40 ligand augments their antigen presenting activity.
    Yanagita S; Hori T; Matsubara Y; Ishikawa T; Uchiyama T
    Br J Haematol; 2004 Feb; 124(4):454-62. PubMed ID: 14984494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis.
    Grant CR; Holder BS; Liberal R; Heneghan MA; Ma Y; Mieli-Vergani G; Vergani D; Longhi MS
    Clin Exp Immunol; 2017 Jul; 189(1):71-82. PubMed ID: 28257599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Squamous cell carcinomas escape immune surveillance via inducing chronic activation and exhaustion of CD8+ T Cells co-expressing PD-1 and LAG-3 inhibitory receptors.
    Mishra AK; Kadoishi T; Wang X; Driver E; Chen Z; Wang XJ; Wang JH
    Oncotarget; 2016 Dec; 7(49):81341-81356. PubMed ID: 27835902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD8
    Tao J; Han D; Gao S; Zhang W; Yu H; Liu P; Fu R; Li L; Shao Z
    J Cell Mol Med; 2020 Jan; 24(1):1046-1058. PubMed ID: 31756785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second- and third-generation drugs for immuno-oncology treatment-The more the better?
    Dempke WCM; Fenchel K; Uciechowski P; Dale SP
    Eur J Cancer; 2017 Mar; 74():55-72. PubMed ID: 28335888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines.
    Liu J; Zhang S; Hu Y; Yang Z; Li J; Liu X; Deng L; Wang Y; Zhang X; Jiang T; Lu X
    J Immunother; 2016 May; 39(4):171-80. PubMed ID: 27070448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated Expression of Tim-3 and PD-1 Immune Checkpoint Receptors on T-CD4+ Lymphocytes of Patients with Asthma.
    Mosayebian A; Koohini Z; Hossein-Nataj H; Abediankenari S; Abedi S; Asgarian-Omran H
    Iran J Allergy Asthma Immunol; 2018 Dec; 17(6):517-525. PubMed ID: 30644695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T cells Exhibit Reduced Signal Transducer and Activator of Transcription 5 Phosphorylation and Upregulated Coinhibitory Molecule Expression After Kidney Transplantation.
    Bouvy AP; Klepper M; Kho MM; Ijzermans JN; Betjes MG; Weimar W; Baan CC
    Transplantation; 2015 Sep; 99(9):1995-2003. PubMed ID: 25769075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cooperation of PD-1 and LAG-3 Contributes to T-Cell Exhaustion in Anaplasma marginale-Infected Cattle.
    Okagawa T; Konnai S; Deringer JR; Ueti MW; Scoles GA; Murata S; Ohashi K; Brown WC
    Infect Immun; 2016 Oct; 84(10):2779-90. PubMed ID: 27430272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased Expression of Multiple Co-Inhibitory Molecules on Malaria-Induced CD8
    Brandi J; Riehn M; Hadjilaou A; Jacobs T
    Front Immunol; 2022; 13():878320. PubMed ID: 35874786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-149-3p reverses CD8
    Zhang M; Gao D; Shi Y; Wang Y; Joshi R; Yu Q; Liu D; Alotaibi F; Zhang Y; Wang H; Li Q; Zhang ZX; Koropatnick J; Min W
    Open Biol; 2019 Oct; 9(10):190061. PubMed ID: 31594465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of CD28 expression associates with severe T-cell exhaustion in acute myeloid leukemia.
    Huang Y; Zheng H; Zhu Y; Hong Y; Zha J; Lin Z; Li Z; Wang C; Fang Z; Yu X; Liu L; Xu B
    Front Immunol; 2023; 14():1139517. PubMed ID: 36960073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells.
    Tassi E; Bergamini A; Wignall J; Sant'Angelo M; Brunetto E; Balestrieri C; Redegalli M; Potenza A; Abbati D; Manfredi F; Cangi MG; Magliacane G; Scalisi F; Ruggiero E; Maffia MC; Trippitelli F; Rabaiotti E; Cioffi R; Bocciolone L; Candotti G; Candiani M; Taccagni G; Schultes B; Doglioni C; Mangili G; Bonini C
    Front Immunol; 2023; 14():1212444. PubMed ID: 37868997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.